Improving diagnosis and treatment of attention deficits in head injured patients - Pharmacological treatment for head injured patients
Phase 1
- Conditions
- Attention difficulties after closed head injury
- Registration Number
- EUCTR2004-004921-89-GB
- Lead Sponsor
- orth Bristol NHS Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
6+ months post closed head injury, persistent attention difficulties, good recovery (Glasgow Outcome Scale equal to 5)
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
History of neurological/psychiatric disorder, drug abuse, cardiac arrhytmia, high blood pressure
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: To provide an objective method to identify which head injured patients with attention deficits benefit from which drug in order to select the effective treatment;Secondary Objective: To improve the diagnosis and treatment of attention deficit after closed head injury, and throught it, the quality of life of these patients and their families. ;Primary end point(s): Normalisation of event-related brain potentials (ERPs), improved behavioural measures
- Secondary Outcome Measures
Name Time Method